Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?

Marcec, Robert; Likic, Robert

Marcec, Robert; Likic, Robert.

Marcec R; School of Medicine, University of Zagreb, Salata 3, Zagreb, Croatia.
Likic R; School of Medicine, University of Zagreb, Salata 3, Zagreb, Croatia. robert.likic@mef.hr.

Clin Pharmacokinet ; 61(9): 1321-1323, 2022 09.

Article in English | MEDLINE | ID: covidwho-1956028

Subject(s)

COVID-19 Drug Treatment; Fluvoxamine; Fluvoxamine/therapeutic use; Humans; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Pharmacokinet Year: 2022 Document Type: Article Affiliation country: S40262-022-01154-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google